secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0000950170-22-021534
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix Q3: net sales $114M, GAAP EPS ($0.53); FY22 adj. EBITDA guidance cut; SeaSpine merger
--------------------------------------------------------------------------------

- Net sales $114.0M, up 1% reported, 5% constant currency; Global Orthopedics grew 19% constant currency.
- GAAP EPS ($0.53) vs ($0.11) prior year; adjusted EPS $0.13 vs $0.10.
- Net loss widened to $10.7M from $2.2M; adjusted net income $2.7M.
- FY2022 guidance lowered: net sales $457-463M, adjusted EBITDA $52-54M (from $53-57M), adjusted EPS $0.40-0.50 (from $0.45-0.55).
- Announced agreement to merge with SeaSpine in all-stock merger of equals on October 11, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017022021534/0000950170-22-021534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017022021534/ofix-20221103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-021534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer